e-journal

Treatment of AnemiaWith Epoetin in Kidney Transplant Recipients

---

Abstract: The aim of this study was to analyze the prevalence and efficacy of renal anemia treated with epoetin in maintenance kidney transplant recipients in Slovenia. By the end of 2009, 107 out of 537 patients (19.9%) had been treated with epoetin.A cohort of 49 patients (45.8%) were
analyzed in detail: 11 patients received epoetin alfa, 18 epoetin beta, 10 darbepoetin alfa, and 10 patients received methoxy polyethylene glycol-epoetin beta. The median epoetin dose was 0.36 mg/kg body weight per week. The median serum laboratory parameters were as follows: hemoglobin 120 g/L, hematocrit 0.36, ferritin 332 ng/mL, transferrin saturation 34%, serum creatinine 145 mmol/L,
serum albumin 41 g/L, intact parathyroid hormone 79 ng/L, and C-reactive protein 3 mg/L. We concluded that the prevalence of renal anemia in kidney transplant recipients treated with epoetin was approximately 20%, and laboratory parameters suggested that the treatment of renal anemia in this study cohort was optimal

---

Ketersediaan

Tidak ada salinan data

Informasi Detail

Judul Seri

Therapeutic Apheresis and Dialysis

No. Panggil

-

Penerbit

: Therapeutic Apheresis and Dialysis International Society for Apheresis., 2011

Deskripsi Fisik

Therapeutic Apheresis and Dialysis 15(3):257–260

Bahasa

English

ISBN/ISSN

doi: 10.1111/j.1744-

Klasifikasi

-

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

-

Edisi

(2011), 15(3)

Subjek

Therapeutic Apheresis and Dialysis

Info Detail Spesifik

-

Pernyataan Tanggungjawab

deliza

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar